Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment-Reference-Cited by-同舟云学术

Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment

Published:2016-03-16 Issue:7 Volume:57 Page:1723-1726
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Schwarzbich Mark-Alexander,Schöning Tilman,Cremer Martin,Lisenko Katharina,Ho Anthony D.,Witzens-Harig Matthias

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1113274

Reference13 articles.

1. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

2. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

3. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

4. Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

5. Hoelzer D, Hiddemann W, Baumann A, et al. High survival rate in adult Burkitt’s lymphoma/leukemia and diffuse large B-cell lymphoma with mediastinal involvement. Blood (Suppl). 2007;110:518.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017;Annals of Medicine;2022-02-23

2. Selective contrast-enhanced computed tomography is appropriate in diffuse large B-cell lymphoma therapy response assessment;European Journal of Haematology;2018-09-11

3. The t(8;14)(q24.1;q32) and its variant translocations: A study of 34 cases;Hematology/Oncology and Stem Cell Therapy;2017-09

4. Review of the bioanalytical methods for the determination of methotrexate and its metabolites inin vitro, preclinical and clinical studies: Case studies and perspectives;Biomedical Chromatography;2016-10-17